VACCINE AGAINST ANTHRAX AND EMPHYSEMATOUS CARBUNCLE ALIVE ASSOCIATED AND METHOD FOR PROPHYLAXIS AGAINST THESE DISEASES

FIELD: veterinary science, production and application of biological products, vaccination, prophylaxis. SUBSTANCE: an associated vaccine is prepared from anthrax strain of 55-VNIIVViM at final concentration being 2.0-2.5 x 1010 spores per 1 cmcm and vaccinal strain of emphysematous carbuncle 2/14 at...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GAVRILOV V.A, IPATENKO N.G, KIRILLOV L.V, BAKULOV I.A, STOROZHEV L.I, PLESKIKH S.A, MANICHEV A.A, NIKOLAJCHUK L.F
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: veterinary science, production and application of biological products, vaccination, prophylaxis. SUBSTANCE: an associated vaccine is prepared from anthrax strain of 55-VNIIVViM at final concentration being 2.0-2.5 x 1010 spores per 1 cmcm and vaccinal strain of emphysematous carbuncle 2/14 at final concentration being 2.0-2.1 x 1010 cells per 1 cmcm . For prophylaxis of anthrax and emphysematous carbuncle in farm animals it is necessary to use an associated vaccine which contains the above mentioned strains. The given vaccine should be introduced subcutaneously in area of the middle third of a neck in cattle aged within 3-6 months at the dose of 1.0-1.1 cmcm , aged above 6 months - 2.0-2.1 cmcm . EFFECT: the given vaccine is of higher immunogenicity, it is also areactogenous and safe to create more prolonged and tense immunity both to anhrax and emphysematous carbuncle in cattle. 2 cl, 2 tbls